Chris O’Connell, formerly president of the company’s Diabetes business, will become executive vice president of the new spinal, diabetes and surgical technologies group.
Reporting to Mr. O’Connell will be Bob Blankemeyer, senior vice president and president of Surgical Technologies; Steve La Neve, senior vice president and president of Spinal and Biologics; Katie Szyman, senior vice president and president of Diabetes; and Tom Tefft, senior vice president and president of neuromodulation.
Read the release on the Medtronic consolidation.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
